A healthcare system model that offered tobacco cessation treatment to smokers being discharged from a hospital produced a higher rate of tobacco abstinence during the three-month program than referral to a state-based telephone quitline. But the advantage disappeared at six months when both treatments produced comparable quit rates, researchers from Massachusetts General Hospital (MGH) have …
At a Glance Among US teens, unsuccessful attempts to quit smoking rose in 2020 after years of decline—a reversal that might relate to the recent rise in vaping. The findings suggest that targeting e-cigarette distribution and use by teens could potentially reduce nicotine use and its harmful health effects. Nicotine use is a habit often …
E-cigarettes may complicate teen attempts to quit nicotine Read More »
by Grace Wade Vapes come in an increasingly wide range of flavours Eduardo Munoz/Getty Images Sales of flavored vapes could soon be severely restricted in the US, ostensibly to protect young people from potential harm. While deterring teenagers from vaping may seem like a step in the right direction, many public health researchers worry that …
Vaping v smoking: Why the FDA is trying to limit access to flavored e-cigarettes Read More »
African Americans have been underrepresented in tobacco treatment research, including the clinical trials that led to the 2006 FDA approval of varenicline, the leading pharmacological treatment for smoking cessation commonly known by the brand name Chantix. Meanwhile, African Americans suffer higher rates of smoking-related disease and death despite smoking fewer cigarettes per day than white …
Varenicline improves quit rates among African American daily smokers Read More »
